D, E., & M, S. (2017). Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: A focus on ribociclib. Dove Medical Press.
Chicago Style (17th ed.) CitationD, Edessa, and Sisay M. Recent Advances of Cyclin-dependent Kinases as Potential Therapeutic Targets in HR+/HER2− Metastatic Breast Cancer: A Focus on Ribociclib. Dove Medical Press, 2017.
MLA (8th ed.) CitationD, Edessa, and Sisay M. Recent Advances of Cyclin-dependent Kinases as Potential Therapeutic Targets in HR+/HER2− Metastatic Breast Cancer: A Focus on Ribociclib. Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.